A deficiency in the prostaglandin D2 receptor CRTH2 exacerbates adjuvant-induced joint inflammation

Journal of Immunology

Volumn 193, Issue 12, 2014, Pages 5835-5840

  Tsubosaka, Yoshiki ^a   Nakamura, Tatsuro ^a   Hirai, Hiroyuki ^b   Hori, Masatoshi ^a   Nakamura, Masataka ^c   Ozaki, Hiroshi ^a   Murata, Takahisa ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Kawagoe shi   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOATTRACTANT RECEPTOR HOMOLOGOUS MOLECULE EXPRESSED ON TH2 CELLS; CHEMOKINE RECEPTOR CXCR2; CLODRONIC ACID; FREUND ADJUVANT; GADOLINIUM CHLORIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PROSTAGLANDIN D2; PROSTAGLANDIN RECEPTOR; UNCLASSIFIED DRUG; IMMUNOGLOBULIN RECEPTOR; IMMUNOLOGICAL ADJUVANT; PROSTAGLANDIN D2 RECEPTOR; PROSTAGLANDIN E2;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE ARTHRITIS; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; IMMUNOCOMPETENT CELL; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PAW EDEMA; PERITONEUM MACROPHAGE; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; DEFICIENCY; EXPERIMENTAL ARTHRITIS; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; MACROPHAGE; MALE; METABOLISM; PATHOLOGY;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ARTHRITIS, EXPERIMENTAL; DINOPROSTONE; DISEASE PROGRESSION; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; PROSTAGLANDIN D2; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN; SIGNAL TRANSDUCTION;

EID: 84916919266     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1303478     Document Type: Article

References (41)

1. Gabriel, S. E. 2001. The epidemiology of rheumatoid arthritis. Rheum. Dis. Clin. North Am. 27: 269-281.
2. Mulherin, D., O. Fitzgerald, and B. Bresnihan. 1996. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum. 39: 115-124.
3. Solomon, S., N. Rajasekaran, E. Jeisy-Walder, S. B. Snapper, and H. Illges. 2005. A crucial role for macrophages in the pathology of K/B X N serum-induced arthritis. Eur. J. Immunol. 35: 3064-3073.
4. Campbell, I. K., M. J. Rich, R. J. Bischof, and J. A. Hamilton. 2000. The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF. J. Leukoc. Biol. 68: 144-150.
5. Plater-Zyberk, C., A. J. Hoogewerf, A. E. Proudfoot, C. A. Power, and T. N. Wells. 1997. Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice. Immunol. Lett. 57: 117-120.
6. Saxne, T., M. A. Palladino, Jr., D. Heinega˚rd, N. Talal, and F. A. Wollheim. 1988. Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum. 31: 1041-1045.
7. Houssiau, F. A., J. P. Devogelaer, J. Van Damme, C. N. de Deuxchaisnes, and J. Van Snick. 1988. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum. 31: 784-788.
8. Mihara, M., Y. Moriya, T. Kishimoto, and Y. Ohsugi. 1995. Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor. Br. J. Rheumatol. 34: 321-325.
9. Lam, J., S. Takeshita, J. E. Barker, O. Kanagawa, F. P. Ross, and S. L. Teitelbaum. 2000. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J. Clin. Invest. 106: 1481-1488.
10. Trang, L. E., E. Granström, and O. Lövgren. 1977. Levels of prostaglandins F2 alpha and E2 and thromboxane B2 in joint fluid in rheumatoid arthritis. Scand. J. Rheumatol. 6: 151-154.
11. Simon, L. S., F. L. Lanza, P. E. Lipsky, R. C. Hubbard, S. Talwalker, B. D. Schwartz, P. C. Isakson, and G. S. Geis. 1998. Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. Arthritis Rheum. 41: 1591-1602.
12. Honda, T., E. Segi-Nishida, Y. Miyachi, and S. Narumiya. 2006. Prostacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis. J. Exp. Med. 203: 325-335.
13. McCoy, J. M., J. R. Wicks, and L. P. Audoly. 2002. The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis. J. Clin. Invest. 110: 651-658.
14. Yao, C., D. Sakata, Y. Esaki, Y. Li, T. Matsuoka, K. Kuroiwa, Y. Sugimoto, and S. Narumiya. 2009. Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat. Med. 15: 633-640.
15. Urade, Y., and O. Hayaishi. 1999. Prostaglandin D2 and sleep regulation. Biochim. Biophys. Acta 1436: 606-615.
16. Eguchi, N., T. Minami, N. Shirafuji, Y. Kanaoka, T. Tanaka, A. Nagata, N. Yoshida, Y. Urade, S. Ito, and O. Hayaishi. 1999. Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice. Proc. Natl. Acad. Sci. USA 96: 726-730.
17. Kostenis, E., and T. Ulven. 2006. Emerging roles of DP and CRTH2 in allergic inflammation. Trends Mol. Med. 12: 148-158.
18. Ajuebor, M. N., A. Singh, and J. L. Wallace. 2000. Cyclooxygenase-2-derived prostaglandin D(2) is an early anti-inflammatory signal in experimental colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 279: G238-G244.
19. Angeli, V., D. Staumont, A. S. Charbonnier, H. Hammad, P. Gosset, M. Pichavant, B. N. Lambrecht, M. Capron, D. Dombrowicz, and F. Trottein. 2004. Activation of the D prostanoid receptor 1 regulates immune and skin allergic responses. J. Immunol. 172: 3822-3829.
20. Monneret, G., S. Gravel, M. Diamond, J. Rokach, and W. S. Powell. 2001. Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. Blood 98: 1942-1948.
21. Hammad, H., M. Kool, T. Soullié, S. Narumiya, F. Trottein, H. C. Hoogsteden, and B. N. Lambrecht. 2007. Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells. J. Exp. Med. 204: 357-367.
22. Murata, T., K. Aritake, Y. Tsubosaka, T. Maruyama, T. Nakagawa, M. Hori, H. Hirai, M. Nakamura, S. Narumiya, Y. Urade, and H. Ozaki. 2013. Antiinflammatory role of PGD2 in acute lung inflammation and therapeutic application of its signal enhancement. Proc. Natl. Acad. Sci. USA 110: 5205-5210.
23. Murata, T., M. I. Lin, K. Aritake, S. Matsumoto, S. Narumiya, H. Ozaki, Y. Urade, M. Hori, and W. C. Sessa. 2008. Role of prostaglandin D2 receptor DP as a suppressor of tumor hyperpermeability and angiogenesis in vivo. Proc. Natl. Acad. Sci. USA 105: 20009-20014.
24. Sarashina, H., Y. Tsubosaka, K. Omori, K. Aritake, T. Nakagawa, M. Hori, H. Hirai, M. Nakamura, S. Narumiya, Y. Urade, et al. 2014. Opposing immunomodulatory roles of prostaglandin D2 during the progression of skin inflammation. J. Immunol. 192: 459-465.
25. Hirai, H., K. Tanaka, O. Yoshie, K. Ogawa, K. Kenmotsu, Y. Takamori, M. Ichimasa, K. Sugamura, M. Nakamura, S. Takano, and K. Nagata. 2001. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J. Exp. Med. 193: 255-261.
26. Tajima, T., T. Murata, K. Aritake, Y. Urade, H. Hirai, M. Nakamura, H. Ozaki, and M. Hori. 2008. Lipopolysaccharide induces macrophage migration via prostaglandin D(2) and prostaglandin E(2). J. Pharmacol. Exp. Ther. 326: 493-501.
27. Spik, I., C. Brénuchon, V. Angéli, D. Staumont, S. Fleury, M. Capron, F. Trottein, and D. Dombrowicz. 2005. Activation of the prostaglandin D2 receptor DP2/CRTH2 increases allergic inflammation in mouse. J. Immunol. 174: 3703-3708.
28. Satoh, T., R. Moroi, K. Aritake, Y. Urade, Y. Kanai, K. Sumi, H. Yokozeki, H. Hirai, K. Nagata, T. Hara, et al. 2006. Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor. J. Immunol. 177: 2621-2629.
29. Chevalier, E., J. Stock, T. Fisher, M. Dupont, M. Fric, H. Fargeau, M. Leport, S. Soler, S. Fabien, M. P. Pruniaux, et al. 2005. Cutting edge: chemoattractant receptor-homologous molecule expressed on Th2 cells plays a restricting role on IL-5 production and eosinophil recruitment. J. Immunol. 175: 2056-2060.
30. Ishii, M., K. Asano, H. Namkoong, S. Tasaka, K. Mizoguchi, T. Asami, H. Kamata, Y. Kimizuka, H. Fujiwara, Y. Funatsu, et al. 2012. CRTH2 is a critical regulator of neutrophil migration and resistance to polymicrobial sepsis. J. Immunol. 188: 5655-5664.
31. Maicas, N., M. L. Ferrándiz, I. Devesa, R. Motterlini, M. I. Koenders, W. B. van den Berg, and M. J. Alcaraz. 2010. The CO-releasing molecule CORM-3 protects against articular degradation in the K/BxN serum transfer arthritis model. Eur. J. Pharmacol. 634: 184-191.
32. Maicas, N., L. Ibáñez, M. J. Alcaraz, A. Úbeda, and M. L. Ferrándiz. 2012. Prostaglandin D2 regulates joint inflammation and destruction in murine collagen-induced arthritis. Arthritis Rheum. 64: 130-140.
33. Chillingworth, N. L., and L. F. Donaldson. 2003. Characterisation of a Freund's complete adjuvant-induced model of chronic arthritis in mice. J. Neurosci. Methods 128: 45-52.
34. Wagner, E. M., J. Sánchez, J. Y. McClintock, J. Jenkins, and A. Moldobaeva. 2008. Inflammation and ischemia-induced lung angiogenesis. Am. J. Physiol. Lung Cell. Mol. Physiol. 294: L351-L357.
35. Chomarat, P., M. C. Rissoan, J. J. Pin, J. Banchereau, and P. Miossec. 1995. Contribution of IL-1, CD14, and CD13 in the increased IL-6 production induced by in vitro monocyte-synoviocyte interactions. J. Immunol. 155: 3645-3652.
36. Takeshita, K., T. Yamasaki, K. Nagao, H. Sugimoto, M. Shichijo, F. Gantner, and K. B. Bacon. 2004. CRTH2 is a prominent effector in contact hypersensitivityinduced neutrophil inflammation. Int. Immunol. 16: 947-959.
37. Jacobs, J. P., A. Ortiz-Lopez, J. J. Campbell, C. J. Gerard, D. Mathis, and C. Benoist. 2010. Deficiency of CXCR2, but not other chemokine receptors, attenuates autoantibody-mediated arthritis in a murine model. Arthritis Rheum. 62: 1921-1932.
38. Campbell, I. K., M. J. Rich, R. J. Bischof, A. R. Dunn, D. Grail, and J. A. Hamilton. 1998. Protection from collagen-induced arthritis in granulocytemacrophage colony-stimulating factor-deficient mice. J. Immunol. 161: 3639-3644.
39. Xue, L., A. Barrow, and R. Pettipher. 2009. Novel function of CRTH2 in preventing apoptosis of human Th2 cells through activation of the phosphatidylinositol 3-kinase pathway. J. Immunol. 182: 7580-7586.
40. Günzl, P., K. Bauer, E. Hainzl, U. Matt, B. Dillinger, B. Mahr, S. Knapp, B. R. Binder, and G. Schabbauer. 2010. Anti-inflammatory properties of the PI3K pathway are mediated by IL-10/DUSP regulation. J. Leukoc. Biol. 88: 1259-1269.
41. Durand, M., M. A. Gallant, and A. J. de Brum-Fernandes. 2008. Prostaglandin D2 receptors control osteoclastogenesis and the activity of human osteoclasts. J. Bone Miner. Res. 23: 1097-1105.